BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 25383523)

  • 21. CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-gamma.
    Herzig S; Hedrick S; Morantte I; Koo SH; Galimi F; Montminy M
    Nature; 2003 Nov; 426(6963):190-3. PubMed ID: 14614508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression.
    Claudel T; Inoue Y; Barbier O; Duran-Sandoval D; Kosykh V; Fruchart J; Fruchart JC; Gonzalez FJ; Staels B
    Gastroenterology; 2003 Aug; 125(2):544-55. PubMed ID: 12891557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition.
    Renga B; Mencarelli A; D'Amore C; Cipriani S; Baldelli F; Zampella A; Distrutti E; Fiorucci S
    FASEB J; 2012 Jul; 26(7):3021-31. PubMed ID: 22447981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restoration of enterohepatic bile acid pathways in pregnant mice following short term activation of Fxr by GW4064.
    Moscovitz JE; Kong B; Buckley K; Buckley B; Guo GL; Aleksunes LM
    Toxicol Appl Pharmacol; 2016 Nov; 310():60-67. PubMed ID: 27609522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postprandial FGF19-induced phosphorylation by Src is critical for FXR function in bile acid homeostasis.
    Byun S; Kim DH; Ryerson D; Kim YC; Sun H; Kong B; Yau P; Guo G; Xu HE; Kemper B; Kemper JK
    Nat Commun; 2018 Jul; 9(1):2590. PubMed ID: 29968724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Farnesoid X receptor interacts with cAMP response element binding protein to modulate glucagon-like peptide-1 (7-36) amide secretion by intestinal L cell.
    Li P; Zhu L; Yang X; Li W; Sun X; Yi B; Zhu S
    J Cell Physiol; 2019 Aug; 234(8):12839-12846. PubMed ID: 30536761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of hepatic autophagy by stress-sensing transcription factor CREBH.
    Kim H; Williams D; Qiu Y; Song Z; Yang Z; Kimler V; Goldberg A; Zhang R; Yang Z; Chen X; Wang L; Fang D; Lin JD; Zhang K
    FASEB J; 2019 Jul; 33(7):7896-7914. PubMed ID: 30912978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nerve growth factor induced farnesoid X receptor upregulation modulates autophagy flux and protects hepatocytes in cholestatic livers.
    Tsai MS; Lee HM; Huang SC; Sun CK; Chiu TC; Chen PH; Lin YC; Hung TM; Lee PH; Kao YH
    Arch Biochem Biophys; 2020 Mar; 682():108281. PubMed ID: 32001246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptional coordination of hepatic autophagy by nutrient-sensing nuclear receptor PPARα and FXR.
    Lee JM
    Ann Pediatr Endocrinol Metab; 2016 Dec; 21(4):193-198. PubMed ID: 28164071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FXR-mediated inhibition of autophagy contributes to FA-induced TG accumulation and accordingly reduces FA-induced lipotoxicity.
    Wu K; Zhao T; Hogstrand C; Xu YC; Ling SC; Chen GH; Luo Z
    Cell Commun Signal; 2020 Mar; 18(1):47. PubMed ID: 32192487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The critical role of FXR is associated with the regulation of autophagy and apoptosis in the progression of AKI to CKD.
    Kim DH; Park JS; Choi HI; Kim CS; Bae EH; Ma SK; Kim SW
    Cell Death Dis; 2021 Mar; 12(4):320. PubMed ID: 33767132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic Autophagy Deficiency Compromises Farnesoid X Receptor Functionality and Causes Cholestatic Injury.
    Khambu B; Li T; Yan S; Yu C; Chen X; Goheen M; Li Y; Lin J; Cummings OW; Lee YA; Friedman S; Dong Z; Feng GS; Wu S; Yin XM
    Hepatology; 2019 May; 69(5):2196-2213. PubMed ID: 30520052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Farnesoid X receptor signaling activates the hepatic X-box binding protein 1 pathway in vitro and in mice.
    Liu X; Guo GL; Kong B; Hilburn DB; Hubchak SC; Park S; LeCuyer B; Hsieh A; Wang L; Fang D; Green RM
    Hepatology; 2018 Jul; 68(1):304-316. PubMed ID: 29377207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FXR Primes the Liver for Intestinal FGF15 Signaling by Transient Induction of β-Klotho.
    Fu T; Kim YC; Byun S; Kim DH; Seok S; Suino-Powell K; Xu HE; Kemper B; Kemper JK
    Mol Endocrinol; 2016 Jan; 30(1):92-103. PubMed ID: 26505219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Farnesoid X Receptor Activation Promotes Hepatic Amino Acid Catabolism and Ammonium Clearance in Mice.
    Massafra V; Milona A; Vos HR; Ramos RJJ; Gerrits J; Willemsen ECL; Ramos Pittol JM; Ijssennagger N; Houweling M; Prinsen HCMT; Verhoeven-Duif NM; Burgering BMT; van Mil SWC
    Gastroenterology; 2017 May; 152(6):1462-1476.e10. PubMed ID: 28130067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic FXR/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice.
    Kim KH; Choi S; Zhou Y; Kim EY; Lee JM; Saha PK; Anakk S; Moore DD
    Hepatology; 2017 Aug; 66(2):498-509. PubMed ID: 28378930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human nuclear pregnane X receptor cross-talk with CREB to repress cAMP activation of the glucose-6-phosphatase gene.
    Kodama S; Moore R; Yamamoto Y; Negishi M
    Biochem J; 2007 Nov; 407(3):373-81. PubMed ID: 17635106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
    Noh K; Kim YM; Kim YW; Kim SG
    Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Farnesoid X receptor antagonizes JNK signaling pathway in liver carcinogenesis by activating SOD3.
    Wang YD; Chen WD; Li C; Guo C; Li Y; Qi H; Shen H; Kong J; Long X; Yuan F; Wang X; Huang W
    Mol Endocrinol; 2015 Feb; 29(2):322-31. PubMed ID: 25496033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.